Due to the expression being in the fraction CD34+/CD38− LSCs, with a phenotype very similar to that of chronic myeloid leukemia (CML), the authors further confirmed the relationship between the two entities [37]. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.